Stem Cells Market, (By Stem Cells Product Type: Adult Stem Cells, Human Embryonic Stem Cells, Induce Pluripotent Stem Cells, Very Small Embryonic Stem Cells. By Applications Type: Regenerative Medicines, Drug Discovery and Other Developments. By Technology Type: Cell Acquisition, Cell Production, Cryopreservation, Expansion and Sub-Culture. By End-User: Therapeutics Companies, Cell and Tissue Banks, Services Companies, Tools and Reagents Companies . By Region - North America, Europe, Asia Pacific, and LAMEA) – Global Industry Insights, Analysis, Trends, and Forecast 2022-2032

The global stem cells market was valued at $ 16.2 billion in 2021 and it is expected to reach $50.7 billion at a CAGR of 10.70% between 2022 and 2032. Stem cells are a type of cells that has the potential to develop into many other types of cells in the human body. It is categorized into two types of cells such as embryonic stem cells and adult stem cells. Furthermore, stem cells can divide and renew themselves over a long time and they can become specialized cells in the human body.                                           

By region, North America is leading the stem cells market across the globe.

The key factors such as increasing demand for biologics, technological advancement in stem cell therapeutics, and a rising focus on the development of personalized medicines are creating new opportunities for the market. The Healthcare system is focusing on the treatment of neurological problems, which is further contributing to the stem cells market expansion. According to the World Health Organization, nearly 8% of the worldwide diseases are cerebrovascular and neurological disorders. Therefore, several companies are managing new and basic research and medical trials to test the regenerative efficiency of stem cells for the treatment of neurological and cerebrovascular conditions. Therefore, new innovative products launches are anticipated to drive the growth of the stem cells market during the forecast period. Furthermore, stem cell banking resource center is also rising, which is expected to drive the growth of the market.                  

Source: SAI Research

Download Free PDF Sample                                                          

Based on product type, the global stem cells market is categorized into adult stem cells, human embryonic stem cells, induced pluripotent stem cells, and very small embryonic stem cells. Among these, the induced pluripotent segment is expected to witness substantial growth during the forecast period from 2022 to 2032. Based on applications, the research application category is estimated to hold a significant growth of the market due to the increasing usage of cell research to study several disorders such as rare diseases, cancer, and Alzheimer's diseases, among others. Based on end-user, the global stem cells market is divided into therapeutics companies, cell and tissue banks, services companies, tools, and reagents companies. Among these, the therapeutics, cells, and tissue companies are expected to propel the growth of the market during the forecast period.                                           

Based on regions, the global market is segmented into North America, Europe, Asia-Pacific, Latin America and Africa, and Middle East Country. Among these regions, North America is leading the stem cells market over the last few years and the region is expected to hold its dominating position in the upcoming years. However, Asia-Pacific is also expected to witness the highest growth per year due to the rising usage of cell lines for research and clinical applications.                                              

According to the study, key players such as Celgene Pharmaceutical Company (U.S), Reneuron Group Biotechnology Company (U.K), Virgin Group Multinational Conglomerate Company (U.K), Biovault Family Limited (U.K), Precious Cells International Limited (Scotland), Opexa Therapeutics Biotechnology Company (U.S), Pluristem Therapeutics Company (Israel), Stemcell Technologies Company (Canada), ThermoGenesis Holdings Commercial Company (U.S), Astellas Pharma Pharmaceutical Company (Japan), Lineage Cell Therapeutics Biotechnology Company (U.S), Mesoblast Company (Australia), Athersys Biotechnology Company (U.S), Cryo-Cell International Company (U.S), Geron Corporation Biotechnology Company (U.S), Verical Company (U.S), Bristol Myers Squibb Pharmaceutical Industry Company (U.S), Merck Group Chemicals Company (Germany), BD Medical Device Company (U.S), Thermo Fisher Scientific Corporation (U.S), Plus Therapeutics Company (U.S), LifeCell International Private Limited (India), StemCyte India Therapeutics Private Limited (India), Reelabs Private Limited (India), Stempeutics Research Private Limited (India), among others are leading the global stem cell market.                      

Scope of the Report:

The Global Stem Cells Market Has Been Segmented Into:

The Global Stem Cells Market – by Stem Cells Product Type:

• Adult Stem Cells
• Human Embryonic Stem Cells
• Induce Pluripotent Stem Cells
• Very Small Embryonic Stem Cells

The Global Stem Cells Market – by Applications Type:

• Regenerative Medicines
• Drug Discovery and Other Developments

The Global Stem Cells Market – by Technology Type:

• Cell Acquisition
• Cell Production
• Cryopreservation
• Expansion and Sub-Culture

The Global Stem Cells Market – by End-User:

• Therapeutics Companies
• Cell and Tissue Banks
• Services Companies
• Tools and Reagents Companies

 The Global Stem Cells Market – by Regions:

North America 

• U.S.
• Canada
• Mexico

Europe

• Germany
• France
• Italy
• U.K.
• Russia
• Rest of Europe Countries

Asia-Pacific

• India
• China
• Japan
• South Korea
• North Korea
• Rest of Asian Countries

Latin America, Middle East & Africa (LAMEA)

• Brazil
• Saudi Arabia
• Rest of LAMEA